Coronary Artery Bypass Grafting Plus Mitral Valve Plasty May Not Provide More Advantage in Patients with Coronary Heart Disease and Moderate Ischemic Mitral Regurgitation: An Inverse Probability of Treatment Weighting Retrospective Cohort Study.
CABG+MVP may not provide more advantage in patients with coronary heart disease and moderate ischemic mitral regurgitation.
Authors
- Jian Cao
- Yue Song (ORCID: https://orcid.org/0000-0003-0898-5281)
- Kaiwen Liu (ORCID: https://orcid.org/0000-0002-4988-4367)
- Jubing Zheng (ORCID: https://orcid.org/0000-0001-7976-8431)
- Taoshuai Liu
- Han Zhang (ORCID: https://orcid.org/0000-0002-2684-512X)
- Kui Zhang (ORCID: https://orcid.org/0000-0002-3176-8616)
- Wei Fu
- Ran Dong (ORCID: https://orcid.org/0000-0003-0205-6852)
- Xiaoyan Gu (ORCID: https://orcid.org/0009-0005-2764-9066)
- Junhang Jia (ORCID: https://orcid.org/0000-0002-1760-9504)
- Yue-Li Wang
Institutions
- Capital Medical University (CN)
- Beijing Anzhen Hospital (CN)
Publication Details
- Journal
- PubMed
- Published
- 2024-11-28
- DOI
- https://doi.org/10.21470/1678-9741-2023-0254
- Citations
- 1
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.40
Funders
- Beijing Nova Program